SGA Global Growth faced Q4 2025 headwinds as cyclical assets outperformed quality growth amid an AI CapEx boom. Read the full ...
Good day, everyone, and welcome to Ascentage Pharma's 2025 Annual Results Earnings Call. [Operator Instructions] As a reminder, today's call is being recorded. Thank you for joining us. I will now ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果